Results 231 to 240 of about 7,355,151 (266)
Some of the next articles are maybe not open access.

Standards for practical allergen‐specific immunotherapy

Allergy, 2006
Foreword The paper was drafted by Emilio Alvarez-Cuesta (chairman), Spain, Jean Bousquet, France, G Walter Canonica, Italy, Stephen Durham, England, Hans-Jorgen Mailing, Denmark and Erkka Valovirta, Finland. The paper was revised and input added by a European Reference Group, endorsed by National Societies associated EAACI and approved by the Executive
Alvarez Cuesta E   +6 more
openaire   +3 more sources

Mechanisms of allergen-specific immunotherapy

Folia Pharmacologica Japonica
Allergen-specific immunotherapy (AIT) has been a longstanding treatment for allergic diseases. Historically, subcutaneous immunotherapy was the main approach, but with the development of sublingual preparations, which are associated with fewer systemic side effects, sublingual immunotherapy is gaining global popularity.
openaire   +2 more sources

Allergen-specific immunotherapy in allergic rhinitis

Current Opinion in Allergy and Clinical Immunology, 2001
The scope of this review is to highlight important and interesting articles in the field of allergen-specific immunotherapy in allergic rhinitis published within the past year. The review is not intended to give a full overview of published literature but rather to focus on some subjects that I find significant in relation to the understanding of the ...
openaire   +2 more sources

Allergen-Specific Immunotherapy with Recombinant Allergens

2011
Subcutaneous immunotherapy is a well-documented treatment of allergic rhinitis and asthma. The major limitation is the risk of anaphylactic side effects. The documentation of clinical efficacy is based on crude allergenic extracts sometimes containing varying amounts of individual allergens including allergens to which the patient may not be sensitized.
G, Pauli, Hans-Jørgen, Malling
openaire   +2 more sources

Immunologic mechanisms of allergen-specific immunotherapy

2001
Allergic diseases basically are immunological disorders, related to activation of a distinct cytokine pattern in T cells, including increased secretion of certain allergic inflammatory cytokines, in particular of IL-4, IL-5 and/or IL-13. (1-3).
Akdis CA, Blaser K
openaire   +3 more sources

Allergen-specific immunotherapy in childhood asthma

Current Opinion in Pediatrics, 1997
Immunotherapy has been shown to prevent rhinitis symptoms in seasonal allergic rhinitis, and to prevent anaphylaxis to hymenoptera and fire ant stings. The evidence supporting its effectiveness in the treatment of asthma is much more limited; it appears that clinical trials, until the past year, have only tested therapy for single allergens such as ...
openaire   +2 more sources

Allergen specific immunotherapy for atopic dermatitis

Current Opinion in Allergy & Clinical Immunology, 2007
To describe recent developments as well as the pros and cons of allergen specific immunotherapy as a putative therapeutic option for a subgroup of patients with atopic dermatitis.The question whether specific immunotherapy would impair or improve the severity and course of atopic dermatitis has been a matter of debate for a long time.
openaire   +2 more sources

Allergen Immunotherapy: Current and Future Trends

Cells, 2022
Ramírez-Jiménez Fernando   +2 more
exaly  

Allergen‐specific immunotherapy to mosquitoes

Allergy, 2001
E, Beaudouin   +3 more
openaire   +2 more sources

Allergen Immunotherapy in Asthma

Pathogens, 2021
Makoto Nagata, Kazuyuki Nakagome
exaly  

Home - About - Disclaimer - Privacy